| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.007 | 1 |